147 related articles for article (PubMed ID: 36427916)
1. Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents.
Liu X; Wang X
Chin J Nat Med; 2022 Nov; 20(11):814-829. PubMed ID: 36427916
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
3. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
Mathema VB; Koh YS; Thakuri BC; Sillanpää M
Inflammation; 2012 Apr; 35(2):560-5. PubMed ID: 21603970
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
[TBL] [Abstract][Full Text] [Related]
6. Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells.
Duan D; Zhang J; Yao J; Liu Y; Fang J
J Biol Chem; 2016 May; 291(19):10021-31. PubMed ID: 27002142
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
[TBL] [Abstract][Full Text] [Related]
8. Microtubule-interfering activity of parthenolide.
Miglietta A; Bozzo F; Gabriel L; Bocca C
Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437
[TBL] [Abstract][Full Text] [Related]
9. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
[TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.
Kwok BH; Koh B; Ndubuisi MI; Elofsson M; Crews CM
Chem Biol; 2001 Aug; 8(8):759-66. PubMed ID: 11514225
[TBL] [Abstract][Full Text] [Related]
11. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.
Tiuman TS; Ueda-Nakamura T; Garcia Cortez DA; Dias Filho BP; Morgado-Díaz JA; de Souza W; Nakamura CV
Antimicrob Agents Chemother; 2005 Jan; 49(1):176-82. PubMed ID: 15616293
[TBL] [Abstract][Full Text] [Related]
12. Covalent modification of human serum albumin by the natural sesquiterpene lactone parthenolide.
Plöger M; Sendker J; Langer K; Schmidt TJ
Molecules; 2015 Apr; 20(4):6211-23. PubMed ID: 25859779
[TBL] [Abstract][Full Text] [Related]
13. Rapid extraction and high-performance liquid chromatographic determination of parthenolide in feverfew (Tanacetum parthenium).
Zhou JZ; Kou X; Stevenson D
J Agric Food Chem; 1999 Mar; 47(3):1018-22. PubMed ID: 10552409
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy.
An T; Yin H; Lu Y; Liu F
Drug Des Devel Ther; 2022; 16():1255-1272. PubMed ID: 35517982
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Sur R; Martin K; Liebel F; Lyte P; Shapiro S; Southall M
Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
[TBL] [Abstract][Full Text] [Related]
16. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
17. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
19. Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.
Bahrami M; Kamalinejad M; Latifi SA; Seif F; Dadmehr M
Phytother Res; 2020 Oct; 34(10):2429-2430. PubMed ID: 32472655
[TBL] [Abstract][Full Text] [Related]
20. The effects of several abiotic elicitors on the expression of genes of key enzymes involved in the parthenolide biosynthetic pathway and its content in feverfew plant (
Darbahani M; Rahaie M; Ebrahimi A; Khosrowshahli M
Nat Prod Res; 2022 Dec; 36(23):6132-6136. PubMed ID: 35356827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
